KR200357603Y1 - Syringe needle for Mezotheraphy - Google Patents
Syringe needle for Mezotheraphy Download PDFInfo
- Publication number
- KR200357603Y1 KR200357603Y1 KR20-2004-0011518U KR20040011518U KR200357603Y1 KR 200357603 Y1 KR200357603 Y1 KR 200357603Y1 KR 20040011518 U KR20040011518 U KR 20040011518U KR 200357603 Y1 KR200357603 Y1 KR 200357603Y1
- Authority
- KR
- South Korea
- Prior art keywords
- needle
- syringe
- mesotherapy
- lipolysis
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000694 mesotherapy Methods 0.000 claims abstract description 30
- 239000003814 drug Substances 0.000 description 27
- 229940079593 drug Drugs 0.000 description 27
- 230000004130 lipolysis Effects 0.000 description 27
- 238000000034 method Methods 0.000 description 25
- 230000000694 effects Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 210000003716 mesoderm Anatomy 0.000 description 9
- 238000007920 subcutaneous administration Methods 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 210000004003 subcutaneous fat Anatomy 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000002366 lipolytic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
- A61M2005/1581—Right-angle needle-type devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/158—Needles for infusions; Accessories therefor, e.g. for inserting infusion needles, or for holding them on the body
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S83/00—Cutting
- Y10S83/929—Particular nature of work or product
- Y10S83/944—Syringe needle
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
본 고안은 주사기의 허브 및 니들로 이루어진 통상의 주사기 니들에 있어서, 니들의 길이가 3∼6㎜이고 니들의 외경이 0.27∼0.33㎜(31∼29G)인 것을 특징으로 하는 메조테라피용 니들에 관한 것이다.The present invention relates to a needle for mesotherapy in a conventional syringe needle consisting of a hub and a needle of a syringe, wherein the needle length is 3 to 6 mm and the outer diameter of the needle is 0.27 to 0.33 mm (31 to 29 G). will be.
Description
본 고안은 피하지방 분해용 주사기에 관한 것으로서, 더욱 상세하게는 주사기 허브 및 니들로 이루어진 통상의 주사기로서 니들의 길이가 3∼6㎜이고 니들의 외경이 0.27∼0.33㎜(31∼29G)인 메조테라피용 니들에 관한 것이다. 본 고안은 피부 밑의 중배엽(mesoderm)에 주사하는 메조테라피(mezotheraphy)용 니들에 관한 것이다.The present invention relates to a subcutaneous fat dissolving syringe, and more particularly, a mesozo having a needle length of 3 to 6 mm and a needle outer diameter of 0.27 to 0.33 mm (31 to 29 G). It is related to the therapy needle. The present invention relates to a needle for mezotheraphy injected into the mesoderm below the skin.
본 고안은 피부 하부의 중배엽에 적합 주사하여 지방 분해를 촉진하는 치료시 사용하는 주사기에 관한 것이다. 메조테라피 약물은 원칙적으로 전신 순환을 통해서 흡수되는 것이 아니라 병변이 있는 부위에만 작용하는 것이다. 메조테라피용 니들를 이용하는 방법으로서 기존의 주사기기를 사용하는 문제점은 현재 시판되는 종래의 제품은 주사기 니들의 길이가 13 ㎜ 밖에 없어 피하지방의 적절한 위치에 주사하기 어렵다는 문제점이 있다. 본 고안은 상기 문제점을 극복하기 위해 주사기 내 니들의 길이를 3 ㎜ 내지 6 ㎜로 하여 주사의 편리성, 신속성을 갖는 피하지방용 주사기의 개발에 관한 것이다.The present invention relates to a syringe for use in therapy that promotes lipolysis by injecting into the mesoderm below the skin. Mesotherapy drugs are not, in principle, absorbed through the systemic circulation, but act only on the site of the lesion. The problem of using a conventional syringe as a method of using a mesotherapy needle has a problem that it is difficult to inject into a proper position of subcutaneous fat because the conventional product currently available is only 13 mm in length. The present invention relates to the development of a subcutaneous fat syringe having the convenience and speed of injection with the needle length of 3 mm to 6 mm in order to overcome the above problems.
지방분해 효과가 있는 여러가지 약물을 피부에 직접 주사해 지방을 분해하는 방법은 프랑스에서 이미 50년 전부터 시술해온 방법이다. 비만크리닉의 시술방법인 메조테리피용 주사시술방법은 지방분해 효과가 있는 약물을 경구 복용하는 경우보다 투여량이 1/10 내지 1/60에 불과할 정도로 적은 양이며, 또한 주사기를 이용할 경우 치료하고자 하는 부위에만 적용하기 용이하므로 약물의 경구 투여보다 부작용이 적다는 것이 가장 큰 장점으로 작용한다. 또한, 메조테리피용 주사시술방법은 약물이 치료하고자 하는 부위에서 서서히 작용하므로서 1회 시술 후 효과가 1주일 정도 발효되는 장점이 있다.Decomposing fat by injecting a variety of lipolytic drugs directly into the skin has been performed in France for 50 years. Mesotherapeutic injection method, obesity clinic treatment method, is only about 1/10 to 1/60 less than oral dose of lipolytic drug, and the area to be treated by using syringe It is easy to apply only, so the side effect is less than oral administration of the drug is the biggest advantage. In addition, the injection method for mesotherapies has the advantage that the effect after the procedure is fermented for about a week because the drug acts slowly at the site to be treated.
메조테라피용 니들를 이용하는 방법은 메조건(mezo gun)을 사용하는 방법과 수작업으로 시술하는 방법으로 나뉜다. 메조건은 주사기 니들의 길이를 조절할 수있다는 장점이 있으나, 메조건의 기계적 특성 및 시술시 장갑을 착용함으로써 시술자의 민감도가 떨어지는 단점으로 인하여 얼굴 부위와 같이 섬세한 부분의 적용하기는 문제점이 있다.Mesotherapy needles are divided into methods using mezo guns and manual procedures. Me conditional has the advantage that the length of the syringe needle can be adjusted, but there is a problem in applying the delicate part such as the face part due to the disadvantage of the sensitivity of the operator by wearing the glove during the mechanical properties of the condition and the procedure.
메조테라피용 니들를 이용하는 방법으로서 수작업으로 시술하는 방법은 얼굴 등 섬세한 부위에 사용하기 적합한 방법이나, 현재까지 시판되는 메조세라피용 주사기의 니들부분의 길이가 13㎜ 내외로 수작업시 피하 4㎜ 내외의 지방층에 정확히 주사하기 위하여 숙련된 테크닉이 필요하다는 단점이 있다.The method of using mesotherapy needles is a method suitable for use on delicate areas such as the face, but the length of the needle portion of the mesotherapy syringes on the market is about 13 mm, and a subcutaneous fat layer of about 4 mm is used during manual operation. There is a disadvantage that skilled techniques are required to inject correctly.
본 고안은 종래 메조테라피용 니들의 문제점인 니들 부분의 길이가 16㎜ 내외로 시술시 적합한 4㎜ 내외의 지방층에 쉽고, 정확하게 주사할 수 없다는 문제점을 개선한 메조테라피용 니들를 개발하는 것이다.The present invention is to develop a needle for mesotherapy which improves the problem that the length of the needle portion, which is a problem of the conventional mesotherapy needle, is about 16 mm and can not be easily and accurately injected into a fat layer of about 4 mm suitable for the procedure.
도1은 종래의 메조테라피용 니들의 사시도를 나타낸 것이다.Figure 1 shows a perspective view of a conventional mesotherapy needle.
도2는 본 고안의 메조테라피용 니들의 사시도를 나타낸 것이다.Figure 2 shows a perspective view of the needle for the mesotherapy of the present invention.
도3은 종래 주사기 니들의 피부 적용시 단면도 및 본고안의 메조테라피용 니들의 피부 적용시 단면도를 나타낸 것이다.Figure 3 shows a cross-sectional view when applying the skin of the conventional syringe needle and a cross-sectional view when applying the skin of the needle for mesotherapy in the present.
*도면의 주요 부분에 대한 부호의 설명** Description of the symbols for the main parts of the drawings *
12: 본 고안의 주사기 니들 14: 본 고안의 주사기 허브12: Syringe Needle of the Invention 14: Syringe Hub of the Invention
102: 종래의 주사기 니들 104: 종래의 주사기 허브102: conventional syringe needle 104: conventional syringe hub
본 고안은 주사기 허브 및 니들로 이루어진 통상의 주사기 니들에 있어서, 니들(12)의 길이가 3∼6㎜이고 니들(12)의 외경이 0.27∼0.33㎜(31∼29G)인 것을 특징으로 하는 메조테라피용 니들에 관한 것이다. 본 고안의 메조테라피용 니들은 길이(h)가 3∼6㎜인 메조테라피용 니들에 관한 것이며 상기 니들의 외경은 0.27∼0.33㎜(31∼29G)인 것이 바람직하다. 상기 니들의 외경 단위(G)는 게이지(gauge)이다. 주사기가 끼워지는 허브의 규격은 국제 규격으로서 전세계 모든 국가가 통일된규격이다.The present invention is a meso, characterized in that, in a conventional syringe needle consisting of a syringe hub and a needle, the length of the needle 12 is 3 to 6 mm and the outer diameter of the needle 12 is 0.27 to 0.33 mm (31 to 29 G). It is related to the therapy needle. The mesotherapy needle of the present invention relates to a mesotherapy needle having a length h of 3 to 6 mm, and the outer diameter of the needle is preferably 0.27 to 0.33 mm (31 to 29 G). The outer diameter unit G of the needle is a gauge. The specification of the hub in which the syringe is inserted is an international standard, which is a universal standard for all countries of the world.
본 고안의 메조테라피용 니들은 니들의 길이(h)가 3∼6㎜이고 니들의 길이가 4㎜인 것이 바람직하다. 본 고안의 메조테라피용 니들에서 니들의 길이가 3㎜ 이하인 경우는 피부 밑의 중배엽 까지 니들이 접촉되지 않기 때문에 메조테라피용 니들로서 기능을 하지 못한다. 또한 본 고안의 메조테라피용 니들에서 니들의 길이가 6㎜ 이상인 경우는 피부 밑의 중배엽을 초과하여 주사시 잘못하면 주사기의 니들이 혈관을 건드리는 부작용이 생길 염려가 있어 메조테라피용 니들로서 기능을 하지 못한다.The mesotherapy needle of the present invention preferably has a needle length h of 3 to 6 mm and a needle length of 4 mm. In the mesotherapy needle of the present invention, when the needle length is 3 mm or less, the needle does not function to the mesoderm below the skin and thus does not function as a mesotherapy needle. In addition, in the mesotherapy needle of the present invention, if the needle length is 6 mm or more, the needle of the syringe may cause a side effect of touching the blood vessel if the needle is inadvertently exceeded, so that it does not function as a mesotherapy needle. .
본 고안의 메조테라피용 니들은 니들의 외경이 0.27∼0.33㎜(31∼29G)이고 니들의 외경이 0.3㎜(29G)인 것이 바람직하다. 본 고안의 메조테라피용 니들에서 니들의 외경이 0.27㎜(31G) 이하인 경우는 약물이 통과하는 니들의 외경이 너무 좁아 약물이 막히거나 니들이 구부러지는 경우가 있어 메조테라피용 니들로서 기능을 하지 못한다. 또한 본 고안의 메조테라피용 니들에서 니들의 외경이 0.33㎜(29G) 이상인 경우는 주사하는 약물의 양이 너무 많이 주사될 수 있는 문제점이 있다.The mesotherapy needle of the present invention preferably has an outer diameter of the needle of 0.27-0.33 mm (31-29 G) and an outer diameter of the needle of 0.3 mm (29 G). In the mesotherapy needle of the present invention, when the outer diameter of the needle is 0.27 mm (31 G) or less, the outer diameter of the needle through which the drug passes is too narrow, so that the drug may be blocked or the needle may be bent, thus not functioning as a mesotherapy needle. In addition, when the outer diameter of the needle in the mesotherapy needle of the present invention is more than 0.33mm (29G) there is a problem that the amount of drug to be injected can be injected too much.
본 고안의 구조를 갖는 메조테라피용 니들의 작용을 기존의 주사기와 대비하여 보다 상세하게 설명하면 다음과 같다.The action of the needle for mesotherapy having the structure of the present invention is described in more detail in comparison with a conventional syringe as follows.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 기존의 주사기 중에서 주사기의 니들이 13㎜인 주사기를 사용하여 주사기의 시술방법으로서 수작업으로 피하 4㎜에 주사하였다. 상기 주사기를 사용하는 경우 상당히 숙련된 테크닉이 필요하며 조금 얕게 주사하는 경우 재주사해야 하는 문제점이 발생하였으며 조금 깊이 주사하는 경우 잘못하면 혈관을 건드리는 부작용이 생길 염려가 있었다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, a syringe having a needle of a syringe of 13 mm was used in the existing syringe and injected into the subcutaneous 4 mm by hand as a surgical method. In the case of using the syringe, a very skilled technique is required, and when the injection is a little shallow, a problem has to be re-injected.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 기존의 주사기 중에서 주사기의 니들이 13㎜인 주사기를 사용하여 주사기의 시술방법으로서 메조건(MEZO GUN)을 사용하여 피하 4㎜에 주사하였다. 상기 메조건을 사용하는 경우 주사기의 니들을 조절할 수 있어 편리하나 섬세하게 시술할 시술부위에는 적합하지 않을 수 있다. 또한 메조건을 사용하는 경우 사용상 불편하고 섬세한 시술을 할 수 없는 문제점이 있다. 또한 메조건은 고가 장비이며 얼굴과 같은 섬세한 부분은 사용할 수 없는 문제점이 있었다.In order to implement a lipolysis-promoting method of directly injecting a drug having a lipolysis effect, a syringe having a needle of 13 mm among the existing syringes was used, and subcutaneous 4 mm using MEZO GUN as a procedure for syringe injection. Was injected. In the case of using the above condition, the needle of the syringe can be adjusted, but it may not be suitable for the surgical site to be delicately treated. In addition, there is a problem that can not be inconvenient to use and delicate procedures when using mecondition. In addition, the mecondition is expensive equipment and there is a problem that delicate parts such as faces cannot be used.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들이 4㎜인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 매우 적합한 것으로 나타났다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, the needle of the present invention was injected subcutaneously using a syringe having a needle of 4 mm. In the case of using the syringe, it was found to be very suitable for use in obesity clinics for promoting lipolysis by injecting a drug effective in lipolysis into subcutaneous mesoderm.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들이 6㎜인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 적합한 것으로 나타났으나 니들의 길이가 너무 짧아 의사가 원하는 시술부위까지 약물을 주사할 수 없는 문제점이 나타났다.In order to implement a lipolysis-promoting method of directly injecting a drug having an effect of lipolysis, the syringe of the present invention was injected subcutaneously using a syringe having a needle of 6 mm. In the case of using the syringe, it was found to be suitable for use in obesity clinics that promote lipolysis by injecting drugs that are effective for lipolysis into subcutaneous mesoderm, but the needle length is too short to the procedure desired by the doctor. The problem of not being able to inject the drug appeared.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들이 3㎜인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 적합한 것으로 나타났으나 니들의 길이가 너무 길어 의사가 원하는 시술부위까지 약물을 주사할 수 없는 문제점이 나타났다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, a syringe of the present invention was injected subcutaneously using a syringe having a needle of 3 mm. In the case of using the syringe, the drug which is effective for lipolysis is appropriately injected into the subdermal mesoderm and is suitable for use in obesity clinics that promote lipolysis. The problem of not being able to inject the drug appeared.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들의 길이가 4㎜이고 니들의 외경이 0.3㎜(29G)인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 매우 적합한 것으로 나타났다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, a syringe of the present invention was injected subcutaneously using a syringe having a needle length of 4 mm and a needle outer diameter of 0.3 mm (29G). In the case of using the syringe, it was found to be very suitable for use in obesity clinics for promoting lipolysis by injecting a drug effective in lipolysis into subcutaneous mesoderm.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들의 길이가 4㎜이고 니들의 외경이 0.27㎜(31G)인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 매우 적합한 것으로 나타났다. 그러나 메조테라피용 니들에서 니들의 외경이 0.27㎜(31G) 이하인 경우는 약물이 통과하는 니들의 외경이 너무 좁아 약물이 막히거나 니들이 구부러지는 경우가 있어 메조테라피용 니들로서 기능을 하지 못하는 것으로 나타났다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, a syringe of the present invention was injected subcutaneously using a syringe having a needle length of 4 mm and a needle outer diameter of 0.27 mm (31 G). In the case of using the syringe, it was found to be very suitable for use in obesity clinics for promoting lipolysis by injecting a drug effective in lipolysis into subcutaneous mesoderm. However, when the outer diameter of the needle in the needle for mesotherapy is less than 0.27mm (31G), the outer diameter of the needle through which the drug passes is too narrow, so that the drug may be blocked or the needle may be bent, so that it does not function as a mesotherapy needle.
지방분해의 효과가 있는 약물을 직접 주사하는 지방분해 촉진방법을 시행하기 위해 본 고안의 주사기로서 니들의 길이가 4㎜이고 니들의 외경이 0.33㎜(29G)인 주사기를 사용하여 피하에 주사하였다. 상기 주사기를 사용한 경우 지방분해에 효과가 있는 약물을 피하의 중배엽에 적합하게 주사하여 지방분해를 촉진하는 비만크리닉용으로 사용하기에 매우 적합한 것으로 나타났다. 그러나 메조테라피용 니들에서 니들의 외경이 0.33㎜(29G) 이상인 경우는 주사하는 약물의 양이 너무 많이 주사될 수 있는 문제점이 나타났다.In order to implement a lipolysis promoting method of directly injecting a drug having an effect of lipolysis, a syringe of the present invention was injected subcutaneously using a syringe having a needle length of 4 mm and a needle outer diameter of 0.33 mm (29G). In the case of using the syringe, it was found to be very suitable for use in obesity clinics for promoting lipolysis by injecting a drug effective in lipolysis into subcutaneous mesoderm. However, when the outer diameter of the needle in the needle for mesotherapy is more than 0.33mm (29G), there was a problem that the amount of drug to be injected can be injected too much.
본 고안의 메조테라피용 니들은 피부에 적용할 경우 피하 4㎜ 내외에 정확히 주사할 수 있어 시술자의 특별한 숙련된 테크닉이 필요하지 않으면서도 빠른 시간 안에 숙련된 자가 아니더라도 누구나 손쉽고 용이하게 시술할 수 있는 의료산업상 매우 유용한 고안이다.The mesotherapy needle of the present invention can be precisely injected into the subcutaneous 4 mm when applied to the skin, so that anyone can be easily and easily treated even if they are not skilled in a short time without requiring any special skill of the operator. It is a very useful design in industry.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20-2004-0011518U KR200357603Y1 (en) | 2004-04-26 | 2004-04-26 | Syringe needle for Mezotheraphy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20-2004-0011518U KR200357603Y1 (en) | 2004-04-26 | 2004-04-26 | Syringe needle for Mezotheraphy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR200357603Y1 true KR200357603Y1 (en) | 2004-07-30 |
Family
ID=49348567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR20-2004-0011518U Ceased KR200357603Y1 (en) | 2004-04-26 | 2004-04-26 | Syringe needle for Mezotheraphy |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR200357603Y1 (en) |
-
2004
- 2004-04-26 KR KR20-2004-0011518U patent/KR200357603Y1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103732277B (en) | Injection device with needle shield for desensitizing the skin | |
| US20150182700A1 (en) | Pressure-sensing automatic injection system | |
| DE60233598D1 (en) | Medical syringe with timer | |
| WO2008139303A2 (en) | A novel device for intradermal injection | |
| CN104010679A (en) | Intubation without bruising | |
| BR0116974B1 (en) | pre-filled intradermal injection device. | |
| KR200357603Y1 (en) | Syringe needle for Mezotheraphy | |
| US20080119797A1 (en) | System with a syringe device and a needle device | |
| WO2010026644A1 (en) | Painless injection needle for medical use | |
| KR20030028749A (en) | Novel needle for medical device and device comprising same | |
| US20110196299A1 (en) | Structure of needle for syringe | |
| KR200434588Y1 (en) | Mezzo needle | |
| DE60019451D1 (en) | MEDICAL DEVICE WITH A RETRACTABLE NEEDLE | |
| KR200426764Y1 (en) | Mezzo needle | |
| CN201008687Y (en) | a needle for injection | |
| KR20170057553A (en) | Apparatus for skin aesthetic of the skin device | |
| KR100761095B1 (en) | Dental needle | |
| KR200414198Y1 (en) | Tissue Repair Needle | |
| KR20210073825A (en) | four-surface cutting part with syringe needle | |
| JP2008212616A (en) | Painless injection needle for medical application | |
| RU187055U1 (en) | The cutaneous device of the system of repeated subcutaneous administration of a solution of medicinal substances | |
| Chao | Achieving Better Results through Proper Instrumentation for Aesthetic Toxin Practice | |
| CN203263952U (en) | Syringe needle for closed treatment of oral mucosa disease | |
| WO2007083857A1 (en) | Syringe needle for soft tissue augmentation | |
| KR0127720Y1 (en) | Herbal Medicine Acupuncture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UA0108 | Application for utility model registration |
Comment text: Application for Utility Model Registration Patent event code: UA01011R08D Patent event date: 20040426 |
|
| REGI | Registration of establishment | ||
| UR0701 | Registration of establishment |
Patent event date: 20040720 Patent event code: UR07011E01D Comment text: Registration of Establishment |
|
| UR1002 | Payment of registration fee |
Start annual number: 1 End annual number: 1 Payment date: 20040427 |
|
| UG1601 | Publication of registration | ||
| UR1001 | Payment of annual fee |
Payment date: 20050517 Start annual number: 2 End annual number: 3 |
|
| T201 | Request for technology evaluation of utility model | ||
| UT0201 | Request for technical evaluation |
Patent event date: 20060816 Comment text: Request for Technology Evaluation of Utility Model Patent event code: UT02011R01D |
|
| UR1001 | Payment of annual fee |
Payment date: 20070423 Start annual number: 4 End annual number: 4 |
|
| J210 | Request for trial for objection to revocation decision | ||
| UJ0210 | Trial for objection to revocation decision |
Comment text: Request for Trial Against Decision on Revocation Patent event code: UJ02102R02D Patent event date: 20070725 Request date: 20070725 Appeal kind category: Appeal against decision of cancellation Appeal identifier: 2007103000161 Decision date: 20071224 |
|
| S901 | Examination by remand of revocation | ||
| US0901 | Examination by remand of revocation | ||
| J204 | Request for invalidation trial [patent] | ||
| UJ0204 | Invalidation trial for utility model registration |
Comment text: Request for Trial Patent event code: UJ02042R01D Patent event date: 20080304 Comment text: Registration of Establishment Patent event code: UJ02041E01I Patent event date: 20040720 Request date: 20080304 Appeal kind category: Invalidation Decision date: 20080624 Appeal identifier: 2008100000619 |
|
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20080304 Effective date: 20080624 |
|
| UJ1301 | Trial decision |
Patent event date: 20080624 Patent event code: UJ13011S05D Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Appeal identifier: 2008100000619 Appeal kind category: Invalidation Decision date: 20080624 Request date: 20080304 |
|
| J2X1 | Appeal (before the patent court) |
Free format text: INVALIDATION |
|
| UJ2001 | Appeal |
Patent event date: 20080624 Patent event code: UJ20011S05I Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event date: 20071224 Patent event code: UJ20011S10I Comment text: Trial Decision on Objection to Revocation Decision Decision date: 20090604 Appeal identifier: 2008200008952 Request date: 20080721 Appeal kind category: Invalidation |
|
| UR1001 | Payment of annual fee |
Payment date: 20080722 Start annual number: 5 End annual number: 5 |
|
| UR1001 | Payment of annual fee |
Payment date: 20090612 Start annual number: 6 End annual number: 6 |
|
| J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20080721 Effective date: 20090604 |
|
| UJ1302 | Judgment (patent court) |
Patent event date: 20090706 Comment text: Written Judgment (Patent Court) Patent event code: UJ13021S01D Request date: 20080721 Decision date: 20090604 Appeal identifier: 2008200008952 Appeal kind category: Invalidation |
|
| J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION |
|
| UJ2002 | Appeal before the supreme court |
Patent event date: 20080624 Patent event code: UJ20021S05I Comment text: Trial Decision on Invalidation (Patent, Utility Model, Industrial Design) Patent event date: 20071224 Patent event code: UJ20021S10I Comment text: Trial Decision on Objection to Revocation Decision Decision date: 20090821 Request date: 20090713 Appeal kind category: Invalidation Appeal identifier: 2009300002081 |
|
| EXTG | Ip right invalidated | ||
| UC2102 | Extinguishment | ||
| J303 | Written judgement (supreme court) |
Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20090713 Effective date: 20090821 |
|
| UJ1303 | Judgment (supreme court) |
Patent event date: 20090901 Patent event code: UJ13031S01D Comment text: Written Judgment (Supreme Court) Request date: 20090713 Appeal kind category: Invalidation Decision date: 20090821 Appeal identifier: 2009300002081 |